Citation: Ch. Adler et al., PERIOPERATIVE USE OF BOTULINUM TOXIN FOR MOVEMENT DISORDER-INDUCED CERVICAL-SPINE DISEASE, Movement disorders, 11(1), 1996, pp. 79-81
Citation: Je. Ahlskog et al., ADJUNCTIVE CABERGOLINE THERAPY OF PARKINSONS-DISEASE - COMPARISON WITH PLACEBO AND ASSESSMENT OF DOSE RESPONSES AND DURATION OF EFFECT, Clinical neuropharmacology, 19(3), 1996, pp. 202-212
Authors:
HUTTON JT
KOLLER WC
AHLSKOG JE
PAHWA R
HURTIG HI
STERN MB
HINER BC
LIEBERMAN A
PFEIFFER RF
RODNITZKY RL
WATERS CH
MUENTER MD
ADLER CH
MORRIS JL
Citation: Jt. Hutton et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 46(4), 1996, pp. 1062-1065
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
CHERNIK DA
DORFLINGER E
YOO K
DAVIS T
HOEHN M
LEWITT P
MONTGOMERY E
MUENTER M
TANNER C
TRUGMAN J
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-276
Citation: Ch. Adler et al., CEREBELLAR-ATAXIA, DYSTONIA, AND TREMOR WITHIN A FAMILY - VARIABLE PHENOTYPES OF A SINGLE GENETIC DISORDER, Movement disorders, 9(2), 1994, pp. 155-160
Authors:
PESTRONK A
CHOKSI R
BIESER K
GOLDSTEIN JM
ADLER CH
CASELLI RJ
GEORGE EB
Citation: A. Pestronk et al., TREATABLE GAIT DISORDER AND POLYNEUROPATHY ASSOCIATED WITH HIGH-TITERSERUM IGM BINDING TO ANTIGENS THAT COPURIFY WITH MYELIN-ASSOCIATED GLYCOPROTEIN, Muscle & nerve, 17(11), 1994, pp. 1293-1300
Authors:
BENNETT KMB
ADLER CH
STELMACH GE
CASTIELLO U
Citation: Kmb. Bennett et al., A KINEMATIC STUDY OF THE REACH TO GRASP MOVEMENT IN A SUBJECT WITH HEMIPARKINSONS DISEASE, Neuropsychologia, 31(7), 1993, pp. 709-716
Authors:
CASTIELLO U
BENNETT KMB
ADLER CH
STELMACH GE
Citation: U. Castiello et al., PERTURBATION OF THE GRASP COMPONENT OF A PREHENSION MOVEMENT IN A SUBJECT WITH HEMIPARKINSONS DISEASE, Neuropsychologia, 31(7), 1993, pp. 717-723